Toronto Dominion Bank’s Novo Nordisk NVO Stock Holding History

Toronto Dominion Bank’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,000	Closed	-$483K	–	2037
2025 Q2	$483K	Buy	+7,000	New	+$476K	﹤0.01%	1188
2025 Q1	–	Sell	-18,700	Closed	-$1.61M	–	1647
2024 Q4	$1.61M	Buy	+18,700	New	+$2.02M	﹤0.01%	976
2019 Q3	–	Sell	-75,200	Closed	-$961K	–	1611
2019 Q2	$961K	Buy	75,200 +25,200	+50%	+$623K	﹤0.01%	975
2019 Q1	$1.31M	Sell	50,000 -7,800	-13%	-$192K	﹤0.01%	931
2018 Q4	$1.33M	Buy	57,800 +37,600	+186%	+$836K	﹤0.01%	846
2018 Q3	$476K	Buy	+20,200	New	+$493K	﹤0.01%	999

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Toronto Dominion Bank's NVO Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Novo Nordisk (NVO) stake by 99% in Q1 2026, selling an estimated $756K and leaving 86 shares worth $3.15K. The position accounts for ﹤0.01% of the portfolio, ranked #1991.

Toronto Dominion Bank first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.96M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Toronto Dominion Bank held 86 shares of Novo Nordisk worth $3.15K as of Q1 2026.
Toronto Dominion Bank sold 15,962 Novo Nordisk shares in Q1 2026, an estimated $756K.
Novo Nordisk made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1991 holding.
Toronto Dominion Bank first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
Toronto Dominion Bank's Novo Nordisk position peaked at $4.96M in Q2 2024.
1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.